InvestorsHub Logo
Followers 14
Posts 649
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Sunday, 04/09/2017 11:48:58 AM

Sunday, April 09, 2017 11:48:58 AM

Post# of 461950
Homeostasis nuron health = top combo drug partner:
A lot of great sleuthing has been done on this board to uncover hidden value within the avxl story... There are so many good aspects to the science and fundamentals of avxl that it is hard to consider all salient features.. So we have the FDA already expressing how important combo drug development is; and we know that pharma companies will never stop trying to come up with new compounds to fight various diseases... The avxl 273 compound is in an enviable position within the framework of what the FDA has expressed (and not just in CNS diseases).... In fact since the sigma receptors are located on every (or almost) organ, and since its MOA is to improve cellular health, and further since it has a proven long term health history, it sure looks like it is the best candidate for EACH and EVERY combo drug for ALL disease.... A goto combo drug for every indication.... (and of course along side of this huge combo potential, initiated by independent companies, avxl will work in parallel to gain approval where it sees optimal configurations)...Equally important, to the combo drug scenario, is that as 273 gets recognized as a number one combo drug, it can be used as this, by being prescribed on an off indication basis .... say after garnering approval for Retts or AD...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News